| Plasmid incompatibility: more compatible than previously thought? N Velappan, D Sblattero, L Chasteen, P Pavlik, ARM Bradbury Protein engineering, design & selection 20 (7), 309-313, 2007 | 124 | 2007 |
| Using phage display to select antibodies recognizing post-translational modifications independently of sequence context JW Kehoe, N Velappan, M Walbolt, J Rasmussen, D King, J Lou, K Knopp, ... Molecular & Cellular Proteomics 5 (12), 2350-2363, 2006 | 104 | 2006 |
| Characteristics of different nucleic acid staining dyes for DNA fragment sizing by flow cytometry X Yan, WK Grace, TM Yoshida, RC Habbersett, N Velappan, JH Jett, ... Analytical chemistry 71 (24), 5470-5480, 1999 | 81 | 1999 |
| Antibodies in proteomics I: generating antibodies A Bradbury, N Velappan, V Verzillo, M Ovecka, L Chasteen, D Sblattero, ... TRENDS in Biotechnology 21 (6), 275-281, 2003 | 78 | 2003 |
| Antibodies in proteomics II: screening, high-throughput characterization and downstream applications A Bradbury, N Velappan, V Verzillo, M Ovecka, L Chasteen, D Sblattero, ... Trends in biotechnology 21 (7), 312-317, 2003 | 74 | 2003 |
| Antibody binding loop insertions as diversity elements C Kiss, H Fisher, E Pesavento, M Dai, R Valero, M Ovecka, R Nolan, ... Nucleic acids research 34 (19), e132-e132, 2006 | 67 | 2006 |
| Rapid identification of pathogenic bacteria by single-enzyme amplified fragment length polymorphism analysis N Velappan, JL Snodgrass, JR Hakovirta, BL Marronea, S Burde Diagnostic microbiology and infectious disease 39 (2), 77-83, 2001 | 59 | 2001 |
| Using T7 phage display to select GFP-based binders M Dai, J Temirov, E Pesavento, C Kiss, N Velappan, P Pavlik, JH Werner, ... Protein Engineering, Design & Selection 21 (7), 413-424, 2008 | 54 | 2008 |
| Epidemiological data challenges: planning for a more robust future through data standards G Fairchild, B Tasseff, H Khalsa, N Generous, AR Daughton, N Velappan, ... Frontiers in Public Health 6, 414526, 2018 | 45 | 2018 |
| Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein N Velappan, JS Martinez, R Valero, L Chasteen, L Ponce, ... Journal of immunological methods 321 (1-2), 60-69, 2007 | 44 | 2007 |
| A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins N Velappan, HE Fisher, E Pesavento, L Chasteen, S D'Angelo, C Kiss, ... Nucleic acids research 38 (4), e22-e22, 2010 | 41 | 2010 |
| A humanized anti-M2 scFv shows protective in vitro activity against influenza J Gabbard, N Velappan, R Di Niro, J Schmidt, CA Jones, SM Tompkins, ... Protein Engineering, Design & Selection 22 (3), 189-198, 2009 | 33 | 2009 |
| Filtering" genic" open reading frames from genomic DNA samples for advanced annotation S D'Angelo, N Velappan, F Mignone, C Santoro, D Sblattero, C Kiss, ... BMC genomics 12, 1-10, 2011 | 29 | 2011 |
| Recombinatorial cloning using heterologous lox sites RW Siegel, N Velappan, P Pavlik, L Chasteen, A Bradbury Genome research 14 (6), 1119-1129, 2004 | 24 | 2004 |
| Fluorescence linked immunosorbant assays using microtiter plates N Velappan, J Clements, C Kiss, R Valero-Aracama, P Pavlik, ... Journal of immunological methods 336 (2), 135-141, 2008 | 20 | 2008 |
| Using phage display selected antibodies to dissect microbiomes for complete de novo genome sequencing of low abundance microbes DW Close, F Ferrara, AEK Dichosa, S Kumar, AR Daughton, HE Daligault, ... BMC microbiology 13, 1-14, 2013 | 17 | 2013 |
| Antibodies in proteomics ARM Bradbury, N Velappan, V Verzillo, M Ovecka, R Marzari, D Sblattero, ... Antibody Engineering: Methods and Protocols, 519-546, 2004 | 11 | 2004 |
| Selection and characterization of FcεRI phospho-ITAM specific antibodies N Velappan, A Mahajan, L Naranjo, P Velappan, N Andrews, N Tiee, ... MAbs 11 (7), 1206-1218, 2019 | 8 | 2019 |
| A gene cluster that encodes histone deacetylase inhibitors contributes to bacterial persistence and antibiotic tolerance in Burkholderia thailandensis SN Micheva-Viteva, M Shakya, SH Adikari, CD Gleasner, N Velappan, ... Msystems 5 (1), 10.1128/msystems. 00609-19, 2020 | 7 | 2020 |
| Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications AM Lillo, N Velappan, JM Kelliher, AJ Watts, SP Merriman, G Vuyisich, ... ImmunoTargets and Therapy, 299-316, 2020 | 6 | 2020 |
